High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trial.
Black African
Dipping pattern
Non-dipping pattern
Uncontrolled hypertension
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
22 05 2021
22 05 2021
Historique:
received:
11
03
2021
accepted:
19
05
2021
entrez:
23
5
2021
pubmed:
24
5
2021
medline:
22
12
2021
Statut:
epublish
Résumé
Dipping of blood pressure (BP) at night is a normal physiological phenomenon. However, a non-dipping pattern is associated with hypertension mediated organ damage, secondary forms of hypertension and poorer long-term outcome. Identifying a non-dipping pattern may be useful in assessing risk, aiding the decision to investigate for secondary causes, initiating treatment, assisting decisions on choice and timing of antihypertensive therapy, and intensifying salt restriction. To estimate the prevalence and factors associated with non-dipping pattern and determine the effect of 6 months of three antihypertensive regimens on the dipping pattern among Black African hypertensive patients. This was a secondary analysis of the CREOLE Study which was a randomized, single blind, three-group trial conducted in 10 sites in 6 Sub-Saharan African countries. The participants were 721 Black African patients, aged between 30 and 79 years, with uncontrolled hypertension and a baseline 24-h ambulatory blood pressure monitoring (ABPM). Dipping was calculated from the average day and average night systolic blood pressure measures. The prevalence of non-dipping pattern was 78% (564 of 721). Factors that were independently associated with non-dipping were: serum sodium > 140 mmol/l (OR = 1.72, 95% CI 1.17-2.51, p-value 0.005), a higher office systolic BP (OR = 1.03, 95% CI 1.01-1.05, p-value 0.003) and a lower office diastolic BP (OR = 0.97, 95% CI 0.95-0.99, p-value 0.03). Treatment allocation did not change dipping status at 6 months (McNemar's Chi There was a high prevalence of non-dipping among Black Africans with uncontrolled hypertension. ABPM should be considered more routinely in Black Africans with uncontrolled hypertension, if resources permit, to help personalise therapy. Further research is needed to understand the mechanisms and causes of non-dipping pattern and if targeting night-time BP improves clinical outcomes. Trial registration ClinicalTrials.gov (NCT02742467).
Sections du résumé
BACKGROUND
Dipping of blood pressure (BP) at night is a normal physiological phenomenon. However, a non-dipping pattern is associated with hypertension mediated organ damage, secondary forms of hypertension and poorer long-term outcome. Identifying a non-dipping pattern may be useful in assessing risk, aiding the decision to investigate for secondary causes, initiating treatment, assisting decisions on choice and timing of antihypertensive therapy, and intensifying salt restriction.
OBJECTIVES
To estimate the prevalence and factors associated with non-dipping pattern and determine the effect of 6 months of three antihypertensive regimens on the dipping pattern among Black African hypertensive patients.
METHODS
This was a secondary analysis of the CREOLE Study which was a randomized, single blind, three-group trial conducted in 10 sites in 6 Sub-Saharan African countries. The participants were 721 Black African patients, aged between 30 and 79 years, with uncontrolled hypertension and a baseline 24-h ambulatory blood pressure monitoring (ABPM). Dipping was calculated from the average day and average night systolic blood pressure measures.
RESULTS
The prevalence of non-dipping pattern was 78% (564 of 721). Factors that were independently associated with non-dipping were: serum sodium > 140 mmol/l (OR = 1.72, 95% CI 1.17-2.51, p-value 0.005), a higher office systolic BP (OR = 1.03, 95% CI 1.01-1.05, p-value 0.003) and a lower office diastolic BP (OR = 0.97, 95% CI 0.95-0.99, p-value 0.03). Treatment allocation did not change dipping status at 6 months (McNemar's Chi
CONCLUSION
There was a high prevalence of non-dipping among Black Africans with uncontrolled hypertension. ABPM should be considered more routinely in Black Africans with uncontrolled hypertension, if resources permit, to help personalise therapy. Further research is needed to understand the mechanisms and causes of non-dipping pattern and if targeting night-time BP improves clinical outcomes. Trial registration ClinicalTrials.gov (NCT02742467).
Identifiants
pubmed: 34022790
doi: 10.1186/s12872-021-02074-7
pii: 10.1186/s12872-021-02074-7
pmc: PMC8141234
doi:
Substances chimiques
Antihypertensive Agents
0
Banques de données
ClinicalTrials.gov
['NCT02742467']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
254Références
Chronobiol Int. 2013 Mar;30(1-2):99-115
pubmed: 23098178
Arch Med Sci. 2019 Mar;15(2):337-342
pubmed: 30899285
Am J Hypertens. 2015 May;28(5):640-8
pubmed: 25376639
Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
Am J Hypertens. 1994 Mar;7(3):217-21
pubmed: 8003271
J Hypertens. 2018 Nov;36(11):2260-2268
pubmed: 29846324
J Hypertens. 2000 Apr;18(4):405-10
pubmed: 10779090
Chronobiol Int. 2015;32(10):1329-42
pubmed: 26587588
Hypertension. 2016 Apr;67(4):693-700
pubmed: 26902495
Circulation. 1997 Sep 16;96(6):1859-62
pubmed: 9323073
J Hum Hypertens. 1997 Feb;11(2):125-31
pubmed: 9140800
Bratisl Lek Listy. 2013;114(3):150-4
pubmed: 23406183
Physiology (Bethesda). 2021 Jan 1;36(1):21-34
pubmed: 33325814
Eur Heart J. 2020 Apr 21;41(16):1606-1607
pubmed: 32306034
J Hypertens Suppl. 1993 Dec;11(5):S294-5
pubmed: 8158392
J Hypertens. 2021 Mar 11;:
pubmed: 33710173
J Hypertens. 1998 Jun;16(6):733-8
pubmed: 9663912
Hypertension. 2008 Apr;51(4):891-8
pubmed: 18316653
Vasc Health Risk Manag. 2013;9:125-33
pubmed: 23569382
J Hypertens. 1998 Dec;16(12 Pt 1):1745-8
pubmed: 9869007
Hypertension. 1999 Aug;34(2):181-6
pubmed: 10454438
J Am Soc Nephrol. 1996 Oct;7(10):2130-4
pubmed: 8915972
Semin Nephrol. 2007 Sep;27(5):565-71
pubmed: 17868794
J Hypertens. 2015 Mar;33(3):454-7
pubmed: 25629359
N Engl J Med. 2019 Jun 20;380(25):2429-2439
pubmed: 30883050
Am J Hypertens. 2009 Oct;22(10):1054-61
pubmed: 19629048
BMJ Open. 2016 Feb 09;6(2):e010313
pubmed: 26861939
J Hypertens. 2007 Dec;25(12):2377-80
pubmed: 17984656
J Am Heart Assoc. 2020 Jan 21;9(2):e013696
pubmed: 31914878
J Hypertens. 1996 Dec;14(12):1427-32
pubmed: 8986925
Am Heart J. 2018 Aug;202:5-12
pubmed: 29800784
PLoS One. 2014 Aug 04;9(8):e104300
pubmed: 25090232
Hypertension. 2009 Sep;54(3):646-51
pubmed: 19581500
Am J Hypertens. 1993 Jan;6(1):1-7
pubmed: 8427656
Circ Res. 2015 Mar 13;116(6):1034-45
pubmed: 25767288
Hypertension. 2000 Mar;35(3):844-51
pubmed: 10720605
J Hum Hypertens. 2002 Jun;16(6):435-8
pubmed: 12037701
Clin Nephrol. 1995 Jun;43(6):382-7
pubmed: 7554522
Blood Press. 2020 Jun;29(3):135-136
pubmed: 32338542
Am J Hypertens. 2012 Jan;25(1):60-6
pubmed: 21866184
N Engl J Med. 2003 Jun 12;348(24):2407-15
pubmed: 12802026
Hypertension. 2009 Mar;53(3):466-72
pubmed: 19171788
Eur Heart J. 2020 Dec 21;41(48):4565-4576
pubmed: 31641769
N Engl J Med. 2006 Jun 1;354(22):2368-74
pubmed: 16738273
Lancet. 1988 Aug 13;2(8607):397
pubmed: 2899801
Am J Hypertens. 2004 Jun;17(6):535-9
pubmed: 15177528
J Hum Hypertens. 2009 Oct;23(10):645-53
pubmed: 19225527
Hypertension. 2000 Jul;36(1):62-7
pubmed: 10904013
Mayo Clin Proc. 1994 Nov;69(11):1108-10
pubmed: 7967766
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Sleep. 1996 Jun;19(5):382-7
pubmed: 8843529
J Hypertens. 2018 Nov;36(11):2185-2192
pubmed: 29846331
Tohoku J Exp Med. 2006 Sep;210(1):57-66
pubmed: 16960346
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
J Clin Sleep Med. 2017 Mar 15;13(3):433-439
pubmed: 27855748
Hypertension. 2006 Oct;48(4):527-33
pubmed: 16940213
J Hum Hypertens. 2000 Jan;14(1):57-64
pubmed: 10673733
J Clin Hypertens (Greenwich). 2017 Jul;19(7):713-721
pubmed: 28692165
Nephrol Dial Transplant. 2006 Jan;21(1):226-7
pubmed: 16204295
Am J Med. 2015 Jan;128(1):14-20
pubmed: 25107387
J Hypertens. 2013 Sep;31(9):1731-68
pubmed: 24029863
Hypertension. 2007 Jun;49(6):1235-41
pubmed: 17389258
PLoS One. 2019 Jul 19;14(7):e0219623
pubmed: 31323041
Chronobiol Int. 2011 Jul;28(6):509-19
pubmed: 21797779